Read the March edition of our People Pathways newsletter here.
Featuring:
✅One Nucleus upcoming courses✅South Carolina visit✅Apprentice opportunity from Domainex✅Industry news and more...
Oh what a night!
A fantastic array of life science innovators met up at the One Nucleus Annual Awards Dinner in London last night to celebrate their incredible achievements.
Many congratulations to the winners and finalists:
Best Performing Therapeutic Discovery Company of the YearWinner: AviadoBioFinalists: Healx, Resolution Therapeutics
Best Performing R&D Platform Development Company of the YearWinner: Constructive BioFinalists: Nuclera, OutSee
Best Performing New Company Creator of the YearWinner: UCL Business LtdFinalists: Deep Science Ventures, Babraham Research Campus
Best…
Discovery Park has successfully concluded its latest Discovery Spark programme, an intensive business growth catalyst supporting early-stage start-ups. Designed to assist innovators refine their commercial strategies, build investor readiness, and connect with likeminded peers and industry specialists, the programme culminated in pitches from 10 pioneering companies dedicated to improving cancer treatment and patient outcomes.
This oncology-themed cohort, supported by Capital Enterprise Network, CRUK, NHS Kent & Medway Cancer Alliance, and the University of Kent, brought together…
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that is marked by synovial inflammation, joint destruction, and systemic complication. Aside from causing great physical distress, RA also significantly adds to the socioeconomic burden posed on society. Because of the complex nature of its pathogenesis and the lack of specific symptoms in the initial stages of the disease, early diagnosis and intervention are very important to prevent severe disease progression.The diagnosis of RA typically relies on a comprehensive assessment of clinical manifestations, imaging techniques,…
iBoxit, a company based at Norwich Research Park, has been named as the winner of the Business Innovation Award at the Broadland and South Norfolk Business Awards 2025. iBoxit is a collaboration between entrepreneur John Farley and the University of East Anglia (UEA) under the tutelage of Prof Sheng Qi.
iBoxit is leading the charge to tackle the environmental impact of expanded polystyrene. Through its innovative development of a new, environmentally-sustainable packaging that uses an intricate mixture of existing plastic and plant-based composite to replace the expanded polystyrene boxes…
o2h discovery is excited to announce Ubiquigent as a winner of the o2h Kickstarter Competition. Ubiquigent Limited (Ubiquigent), a revenue- and IP-generating drug discovery company dedicated to enabling deubiquitinase (DUB)-focused drug discovery.
As part of the program, o2h discovery will provide Ubiquigent with access to chemists and associated end-to-end expertise to support its development of a novel portfolio of DUB-targeting compounds to enable the development of DUB-based therapeutics in partnership with its pharma and biotech partners.
The development of DUB-targeting compounds is…
• The top 20 global pharma companies, as a cohort, saw their combined R&D returns rise to 5.9% in 2024, up from 4.3% in 2023;
• GLP-1 drugs - which treat obesity and diabetes – are fuelling the surge, accounting for 2% of pharma’s forecast returns;
• Average cost to develop a drug has risen to $2.2 billion in 2024, up from $2.1 billion in 2023;
• 29 new ‘blockbuster assets’ (drugs with annual sales of at least $1 billion) have entered the drug development pipeline in 2024, up from 19 in 2023.
The return on investment in pharma research and development (R&D) has increased from the…
21 March 2025
Ahead of the long-awaited Industrial Strategy for life sciences, RSM UK calls on the government to address challenges around capital, talent and access to markets if the UK’s life sciences sector is to become an industry leader on the global stage.
The UK’s life sciences sector comprises over 6,800 businesses, generating more than £100bn in turnover in 2021/22. The sector relies heavily on the UK’s research and development (R&D) scheme as a form of funding, with the pharmaceutical industry accounting for 18% of all UK R&D in 2022 – the highest of any…
Cancer Research Horizons, the innovation arm of Cancer Research UK, launches the Cancer Impact Club, a community of business builders whose philanthropy, expertise and networks will help shape the future of cancer treatment. The club has recruited 13 members already, raising £1.3m of its £5m target.
Advances in biomedical understanding, technology and machine learning have brought us to the threshold of a golden age of scientific discovery. However, far too many potentially breakthrough innovations are lost in the funding gap between cutting-edge academic cancer research and a start-up…
On Friday 14 March, as part of a two-day visit to the East of England organised by Andrew Wood, Hon Dutch Consul for East Anglia with support from Norfolk County Council’s Inward Investment Team, Dutch Ambassador to the UK, Paul Huijts, visited scientists at some of the world-leading research institutes at Norwich Research Park.
After a networking lunch at which Nick Talbot, Executive Director and Group Leader of The Sainsbury Laboratory, provided the Ambassador with an overview of the park campus, Mr Huijts met with scientists at the leading edge of research into the role of the gut…